Global PD-L1 Biomarker Testing Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the PD-L1 Biomarker Testing market will register a 45.7%% CAGR in terms of revenue, the global market size will reach $ 3000.1 million by 2025, from $ 665.8 million in 2019. In particular, this report presents the global revenue market share of key companies in PD-L1 Biomarker Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of PD-L1 Biomarker Testing market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the PD-L1 Biomarker Testing, covering the supply chain analysis, impact assessment to the PD-L1 Biomarker Testing market size growth rate in several scenarios, and the measures to be undertaken by PD-L1 Biomarker Testing companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital
Diagnostic Center
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Agilent Technologies
Junshi Biosciences
Roche
Bristol-Myers Squibb
AstraZeneca
Merck
Innovent
Ono Pharmaceutical
Hengrui Medicine
Regeneron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global PD-L1 Biomarker Testing market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of PD-L1 Biomarker Testing market by identifying its various subsegments.
Focuses on the key global PD-L1 Biomarker Testing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the PD-L1 Biomarker Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of PD-L1 Biomarker Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size 2015-2025
2.1.2 PD-L1 Biomarker Testing Market Size CAGR by Region
2.2 PD-L1 Biomarker Testing Segment by Type
2.2.1 PD-L1 (22C3)
2.2.2 PD-L1 (22C3)
2.2.3 PD-L1 (SP142)
2.2.4 PD-L1 (SP263)
2.2.5 Other
2.3 PD-L1 Biomarker Testing Market Size by Type
2.3.1 Global PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
2.3.2 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (2015-2020)
2.4 PD-L1 Biomarker Testing Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Center
2.4.3 Others
2.5 PD-L1 Biomarker Testing Market Size by Application
2.5.1 Global PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
2.5.2 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (2015-2020)
3 Global PD-L1 Biomarker Testing by Players
3.1 Global PD-L1 Biomarker Testing Market Size Market Share by Players
3.1.1 Global PD-L1 Biomarker Testing Market Size by Players (2018-2020)
3.1.2 Global PD-L1 Biomarker Testing Market Size Market Share by Players (2018-2020)
3.2 Global PD-L1 Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PD-L1 Biomarker Testing by Regions
4.1 PD-L1 Biomarker Testing Market Size by Regions
4.2 Americas PD-L1 Biomarker Testing Market Size Growth
4.3 APAC PD-L1 Biomarker Testing Market Size Growth
4.4 Europe PD-L1 Biomarker Testing Market Size Growth
4.5 Middle East & Africa PD-L1 Biomarker Testing Market Size Growth
5 Americas
5.1 Americas PD-L1 Biomarker Testing Market Size by Countries
5.2 Americas PD-L1 Biomarker Testing Market Size by Type
5.3 Americas PD-L1 Biomarker Testing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC PD-L1 Biomarker Testing Market Size by Regions
6.2 APAC PD-L1 Biomarker Testing Market Size by Type
6.3 APAC PD-L1 Biomarker Testing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe PD-L1 Biomarker Testing by Countries
7.2 Europe PD-L1 Biomarker Testing Market Size by Type
7.3 Europe PD-L1 Biomarker Testing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa PD-L1 Biomarker Testing by Countries
8.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type
8.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global PD-L1 Biomarker Testing Market Forecast
10.1 Global PD-L1 Biomarker Testing Market Size Forecast (2021-2025)
10.2 Global PD-L1 Biomarker Testing Forecast by Regions
10.2.1 Global PD-L1 Biomarker Testing Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global PD-L1 Biomarker Testing Forecast by Type
10.8 Global PD-L1 Biomarker Testing Forecast by Application
11 Key Players Analysis
11.1 Agilent Technologies
11.1.1 Company Details
11.1.2 PD-L1 Biomarker Testing Product Offered
11.1.3 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Agilent Technologies News
11.2 Junshi Biosciences
11.2.1 Company Details
11.2.2 PD-L1 Biomarker Testing Product Offered
11.2.3 Junshi Biosciences PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Junshi Biosciences News
11.3 Roche
11.3.1 Company Details
11.3.2 PD-L1 Biomarker Testing Product Offered
11.3.3 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Roche News
11.4 Bristol-Myers Squibb
11.4.1 Company Details
11.4.2 PD-L1 Biomarker Testing Product Offered
11.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bristol-Myers Squibb News
11.5 AstraZeneca
11.5.1 Company Details
11.5.2 PD-L1 Biomarker Testing Product Offered
11.5.3 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 AstraZeneca News
11.6 Merck
11.6.1 Company Details
11.6.2 PD-L1 Biomarker Testing Product Offered
11.6.3 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Merck News
11.7 Innovent
11.7.1 Company Details
11.7.2 PD-L1 Biomarker Testing Product Offered
11.7.3 Innovent PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Innovent News
11.8 Ono Pharmaceutical
11.8.1 Company Details
11.8.2 PD-L1 Biomarker Testing Product Offered
11.8.3 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Ono Pharmaceutical News
11.9 Hengrui Medicine
11.9.1 Company Details
11.9.2 PD-L1 Biomarker Testing Product Offered
11.9.3 Hengrui Medicine PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Hengrui Medicine News
11.10 Regeneron
11.10.1 Company Details
11.10.2 PD-L1 Biomarker Testing Product Offered
11.10.3 Regeneron PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Regeneron News
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. PD-L1 Biomarker Testing Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of PD-L1 (22C3)
Table 5. Major Players of PD-L1(28-8)
Table 6. Major Players of PD-L1 (SP142)
Table 7. Major Players of PD-L1 (SP263)
Table 8. Major Players of Other
Table 9. PD-L1 Biomarker Testing Market Size by Type (2014-2019) ($ Millions)
Table 10. Global PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
Table 11. Global PD-L1 Biomarker Testing Market Size by Application (2015-2020) ($ Millions)
Table 12. Global PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
Table 13. Global PD-L1 Biomarker Testing Revenue by Players (2018-2020) ($ Millions)
Table 14. Global PD-L1 Biomarker Testing Revenue Market Share by Players (2018-2020)
Table 15. Global PD-L1 Biomarker Testing Key Players Head office and Products Offered
Table 16. PD-L1 Biomarker Testing Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global PD-L1 Biomarker Testing Market Size by Regions 2015-2020 ($ Millions)
Table 20. Global PD-L1 Biomarker Testing Market Size Market Share by Regions 2015-2020
Table 21. Americas PD-L1 Biomarker Testing Market Size by Countries (2015-2020) ($ Millions)
Table 22. Americas PD-L1 Biomarker Testing Market Size Market Share by Countries (2015-2020)
Table 23. Americas PD-L1 Biomarker Testing Market Size by Type (2015-2020) ($ Millions)
Table 24. Americas PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
Table 25. Americas PD-L1 Biomarker Testing Market Size by Application (2015-2020) ($ Millions)
Table 26. Americas PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
Table 27. APAC PD-L1 Biomarker Testing Market Size by Regions (2015-2020) ($ Millions)
Table 28. APAC PD-L1 Biomarker Testing Market Size Market Share by Regions (2015-2020)
Table 29. APAC PD-L1 Biomarker Testing Market Size by Type (2015-2020) ($ Millions)
Table 30. APAC PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
Table 31. APAC PD-L1 Biomarker Testing Market Size by Application (2015-2020) ($ Millions)
Table 32. APAC PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
Table 33. Europe PD-L1 Biomarker Testing Market Size by Countries (2015-2020) ($ Millions)
Table 34. Europe PD-L1 Biomarker Testing Market Size Market Share by Countries (2015-2020)
Table 35. Europe PD-L1 Biomarker Testing Market Size by Type (2015-2020) ($ Millions)
Table 36. Europe PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
Table 37. Europe PD-L1 Biomarker Testing Market Size by Application (2015-2020) ($ Millions)
Table 38. Europe PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
Table 39. Middle East & Africa PD-L1 Biomarker Testing Market Size by Countries (2015-2020) ($ Millions)
Table 40. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Countries (2015-2020)
Table 41. Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2015-2020) ($ Millions)
Table 42. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
Table 43. Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2015-2020) ($ Millions)
Table 44. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Application (2015-2020)
Table 45. Key and Potential Regions of PD-L1 Biomarker Testing
Table 46. Key Application and Potential Industries of PD-L1 Biomarker Testing
Table 47. Key Challenges of PD-L1 Biomarker Testing
Table 48. Key Trends of PD-L1 Biomarker Testing
Table 49. Global PD-L1 Biomarker Testing Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 50. Global PD-L1 Biomarker Testing Market Size Market Share Forecast by Regions
Table 51. Global PD-L1 Biomarker Testing Market Size Forecast by Type (2021-2025) ($ Millions)
Table 52. Global PD-L1 Biomarker Testing Market Size Market Share Forecast by Type (2021-2025)
Table 53. Global PD-L1 Biomarker Testing Market Size Forecast by Application (2021-2025) ($ Millions)
Table 54. Global PD-L1 Biomarker Testing Market Size Market Share Forecast by Application (2021-2025)
Table 55. Agilent Technologies Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 56. Agilent Technologies PD-L1 Biomarker Testing Product Offered
Table 57. Agilent Technologies PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 58. Agilent Technologies Main Business
Table 59. Agilent Technologies Latest Developments
Table 60. Junshi Biosciences Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 61. Junshi Biosciences PD-L1 Biomarker Testing Product Offered
Table 62. Junshi Biosciences Main Business
Table 63. Junshi Biosciences PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 64. Junshi Biosciences Latest Developments
Table 65. Roche Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 66. Roche PD-L1 Biomarker Testing Product Offered
Table 67. Roche Main Business
Table 68. Roche PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 69. Roche Latest Developments
Table 70. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 71. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Offered
Table 72. Bristol-Myers Squibb Main Business
Table 73. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 74. Bristol-Myers Squibb Latest Developments
Table 75. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 76. AstraZeneca PD-L1 Biomarker Testing Product Offered
Table 77. AstraZeneca Main Business
Table 78. AstraZeneca PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 79. AstraZeneca Latest Developments
Table 80. Merck Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 81. Merck PD-L1 Biomarker Testing Product Offered
Table 82. Merck Main Business
Table 83. Merck PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 84. Merck Latest Developments
Table 85. Innovent Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 86. Innovent PD-L1 Biomarker Testing Product Offered
Table 87. Innovent Main Business
Table 88. Innovent PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 89. Innovent Latest Developments
Table 90. Ono Pharmaceutical Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 91. Ono Pharmaceutical PD-L1 Biomarker Testing Product Offered
Table 92. Ono Pharmaceutical Main Business
Table 93. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 94. Ono Pharmaceutical Latest Developments
Table 95. Hengrui Medicine Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 96. Hengrui Medicine PD-L1 Biomarker Testing Product Offered
Table 97. Hengrui Medicine Main Business
Table 98. Hengrui Medicine PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 99. Hengrui Medicine Latest Developments
Table 100. Regeneron Details, Company Total Revenue (in $ million), Head Office, PD-L1 Biomarker Testing Major Market Areas and Its Competitors
Table 101. Regeneron PD-L1 Biomarker Testing Product Offered
Table 102. Regeneron Main Business
Table 103. Regeneron PD-L1 Biomarker Testing Revenue and Gross Margin (2018-2020E)
Table 104. Regeneron Latest Developments
List of Figures
Figure 1. PD-L1 Biomarker Testing Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global PD-L1 Biomarker Testing Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global PD-L1 Biomarker Testing Market Size Market Share by Type (2015-2020)
Figure 5. Global PD-L1 (22C3) Market Size Growth Rate
Figure 6. Global PD-L1(28-8) Market Size Growth Rate
Figure 7. Global PD-L1 (SP142) Market Size Growth Rate
Figure 8. Global PD-L1 (SP263) Market Size Growth Rate
Figure 9. Global Other Market Size Growth Rate
Figure 10. PD-L1 Biomarker Testing in Hospital
Figure 11. Global PD-L1 Biomarker Testing Market: Hospital (2015-2020) ($ Millions)
Figure 12. PD-L1 Biomarker Testing in Diagnostic Center
Figure 13. Global PD-L1 Biomarker Testing Market: Diagnostic Center (2015-2020) ($ Millions)
Figure 14. PD-L1 Biomarker Testing in Others
Figure 15. Global PD-L1 Biomarker Testing Market: Others (2015-2020) ($ Millions)
Figure 16. Global Others YoY Growth ($ Millions)
Figure 17. Global PD-L1 Biomarker Testing Market Size Market Share by Application in 2019
Figure 18. Global PD-L1 Biomarker Testing Market Size Market Share by Regions 2015-2020
Figure 19. Americas PD-L1 Biomarker Testing Market Size 2015-2020 ($ Millions)
Figure 20. APAC PD-L1 Biomarker Testing Market Size 2015-2020 ($ Millions)
Figure 21. Europe PD-L1 Biomarker Testing Market Size 2015-2020 ($ Millions)
Figure 22. Middle East & Africa PD-L1 Biomarker Testing Market Size 2015-2020 ($ Millions)
Figure 23. Americas PD-L1 Biomarker Testing Market Size Market Share by Countries in 2019
Figure 24. Americas PD-L1 Biomarker Testing Market Size Market Share by Type in 2019
Figure 25. Americas PD-L1 Biomarker Testing Market Size Market Share by Application in 2019
Figure 26. United States PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 27. Canada PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 28. Mexico PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 29. APAC PD-L1 Biomarker Testing Market Size Market Share by Regions in 2019
Figure 30. APAC PD-L1 Biomarker Testing Market Size Market Share by Type in 2019
Figure 31. APAC PD-L1 Biomarker Testing Market Size Market Share by Application in 2019
Figure 32. China PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 33. Japan PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 34. Korea PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 35. Southeast Asia PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 36. India PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 37. Australia PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 38. Europe PD-L1 Biomarker Testing Market Size Market Share by Countries in 2019
Figure 39. Europe PD-L1 Biomarker Testing Market Size Market Share by Type in 2019
Figure 40. Europe PD-L1 Biomarker Testing Market Size Market Share by Application in 2019
Figure 41. Germany PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 42. France PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 43. UK PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 44. Italy PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 45. Russia PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 46. Spain PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 47. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Countries in 2019
Figure 48. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Type in 2019
Figure 49. Middle East & Africa PD-L1 Biomarker Testing Market Size Market Share by Application in 2019
Figure 50. Egypt PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 51. South Africa PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 52. Israel PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 53. Turkey PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 54. GCC Countries PD-L1 Biomarker Testing Market Size Growth 2015-2020 ($ Millions)
Figure 55. Global PD-L1 Biomarker Testing arket Size Forecast (2021-2025) ($ Millions)
Figure 56. Americas PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 57. APAC PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 58. Europe PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 59. Middle East & Africa PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 60. United States PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 61. Canada PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 62. Mexico PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 63. Brazil PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 64. China PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 65. Japan PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 66. Korea PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 67. Southeast Asia PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 68. India PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 69. Australia PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 70. Germany PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 71. France PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 72. UK PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 73. Italy PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 74. Russia PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 75. Spain PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 76. Egypt PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 77. South Africa PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 78. Israel PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 79. Turkey PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
Figure 80. GCC Countries PD-L1 Biomarker Testing Market Size 2021-2025 ($ Millions)
